Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 31, 2025 • 4:51 PM ET

Date/Time Source News Release
03/31/2025 07:00 AM EDT GlobeNewswire Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms
03/30/2025 07:00 PM EDT Newsfile Quantum BioPharma Provides Corporate Update
03/28/2025 04:30 AM EDT GlobeNewswire Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
03/27/2025 07:00 AM EDT GlobeNewswire Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors
03/26/2025 07:00 AM EDT GlobeNewswire Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd(TM) Alcohol Detox Product Lineup for Retail Sales
03/20/2025 07:30 AM EDT GlobeNewswire Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
02/26/2025 07:30 AM EST GlobeNewswire Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
02/18/2025 07:30 AM EST GlobeNewswire Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
02/11/2025 07:30 AM EST GlobeNewswire Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
02/10/2025 07:30 AM EST GlobeNewswire Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
Page
  • 1
  • 2

Additional News

As of March 31, 2025 • 4:51 PM ET

Date/Time Source News Release
03/31/2025 09:15 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Closes $5 Million Offering to Advance Drug Development
03/28/2025 10:03 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Q4 and Full-Year 2024 Financial Results, Highlights Breakthroughs in Alcohol Detox and MS Treatments
03/28/2025 04:41 AM EDT SeekingAlpha Quantum BioPharma reports FY results
03/27/2025 09:05 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Appoints Terry Lynch to Board, Grants Options
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:30 AM EDT US Earnings Reports Expected earnings - Quantum Biopharma Ltd.
03/26/2025 09:25 AM EDT 24/7 Market News Quantum BioPharma's unbuzzd Goes Ultra-Portable with Celly Nutrition's New Retail Push
03/26/2025 09:05 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Launches Retail-Ready unbuzzd Stick Packs Across U.S. Stores
03/20/2025 08:09 AM EDT SeekingAlpha Quantum Group purchases additional $1.5M worth of Bitcoin
03/17/2025 02:36 PM EDT Stock Traders Daily Where are the Opportunities in (QNTM)
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.